Previous 10 | Next 10 |
SARASOTA, Fla. , Nov. 14, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today a...
SARASOTA, Fla. , Nov. 12, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, ...
SARASOTA, Fla. , Nov. 7, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, t...
SARASOTA, Fla. , Nov. 5, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, is ple...
SARASOTA, Fla. , Oct. 31, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of the FDA cleared INVOcell®, the world's only in vivo Intravaginal Cultu...
SARASOTA, Fla. , Oct. 24, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today...
INVO Bioscience ( OTCQB:IVOB -3.2% ) announces the appointment of Steven Shum as the Chief Executive Officer, effective immediately. More news on: INVO Bioscience, Inc., Healthcare stocks news, Read more ...
SARASOTA, Fla. , Oct. 14, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility & developers of INVOcell®, the first FDA-cleared Intravaginal Culture System, tod...
SARASOTA, Fla. , Oct. 1, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company which was granted FDA clearance for the first Intravaginal Culture System, INVOcell ® , announced today that the Company will exhibit at the American Society for Reprodu...
SARASOTA, Fla. , Aug. 14, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company which was granted FDA clearance for its Intravaginal Culture System, INVOcell ® , today announced financial results for the second quarter of 2019, ended June 30, 2019 . ...
News, Short Squeeze, Breakout and More Instantly...
INVO BioScience, Inc. Company Name:
IVOB Stock Symbol:
OTCMKTS Market:
INVO BioScience, Inc. Website:
SARASOTA, Fla. , May 15, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today anno...
SARASOTA, Fla. , April 2, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO) , a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, announced today the appointment of Christopher A. Myer as Vice President Business Development ...
SARASOTA, Fla. , March 11, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, today announced that Yve Lyppens has been appointed Director Business Development Asia Pacific....